Technical Data
P3105-17Y3
Papilloma Virus Type 16 E7 Protein (E7, HPV16 E7, HpV16gp2, Links Transforming Protein Human Papillomavirus 16, Protein E7, Transforming Protein, Transforming Protein Human Papillomavirus 16)
|
Technical Data |
|
P3105-17Y3 |
Papilloma Virus Type 16 E7 Protein (E7, HPV16 E7, HpV16gp2, Links Transforming Protein Human Papillomavirus 16, Protein E7, Transforming Protein, Transforming Protein Human Papillomavirus 16) |
|
|
Description: Human papillomavirus (HPV) is a diverse group of DNA-based viruses that infect skin and mucous membranes of humans and animals. Some HPV types are the causative agents of cervical cancer, with types 16 and 18 being particularly high-risk. The viral proteins E6 and E7 disrupt normal cell cycle regulation by interacting with p53 (a tumor-suppressing transcription factor) and Rb (retinoblastoma protein, also a tumor-supressor). E7 particularly binds to Rb and histone deacetylases, resulting in activation of the E2F genes, which code for a family of transcription factors. The viral proteins E6 and E7 might be of particular interest in the development of therapeutic vaccines, since they are expressed early in viral infection. Applications: Suitable for use in ELISA and Western Blot. Other applications not tested. Recommended Dilution: Western Blot: 1:1000-1:2000 Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
|
|||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||